newsfilter
← Latest News
PR Newswire·

Elevation Oncology to Participate at Upcoming Investor Conferences

NEW YORK, March 1, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (NASDAQ:ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of